SOPHiA GENETICS SA Sets Annual Shareholder Meeting for June 18

TL;DR

SOPHIA GENETICS AGM IS JUNE 18TH - MARK YOUR CALENDARS

AI Summary

SOPHiA GENETICS SA announced its annual general meeting of shareholders will be held on June 18, 2025, at 8:00 a.m. EDT / 2:00 p.m. CEST in Rolle, Switzerland. The company provided shareholders with an invitation to this meeting.

Why It Matters

This filing informs shareholders about the upcoming annual general meeting, a key event for corporate governance and strategic decisions.

Risk Assessment

Risk Level: low — This is a routine corporate filing announcing a shareholder meeting, with no immediate financial or operational risks indicated.

Key Players & Entities

• SOPHiA GENETICS SA (company) — Registrant
• June 18, 2025 (date) — Annual General Meeting Date
• Daan van Well (person) — Chief Legal Officer

FAQ

From the Filing

0001840706-25-000015.txt : 20250508 0001840706-25-000015.hdr.sgml : 20250508 20250508142303 ACCESSION NUMBER: 0001840706-25-000015 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250508 FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOPHiA GENETICS SA CENTRAL INDEX KEY: 0001840706 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40627 FILM NUMBER: 25925351 BUSINESS ADDRESS: STREET 1: LA PIECE, CH-1180 CITY: ROLLE STATE: V8 ZIP: 00000 BUSINESS PHONE: 41 21 694 10 60 MAIL ADDRESS: STREET 1: LA PIECE, CH-1180 CITY: ROLLE STATE: V8 ZIP: 00000 6-K 1 agm2025sophiageneticssa6-k.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025. ____________________________________ Commission File Number: 001-40627 SOPHiA GENETICS SA (Exact name of registrant as specified in its charter) La Pièce 12 CH-1180 Rolle Switzerland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F x Form 40-F SIGNATURE SOPHiA GENETICS SA (the “Company”) provided to its shareholders an invitation to the Company’s annual general meeting of shareholders. The annual general meeting of shareholders is expected to take place on June 18, 2025 at 8:00 a.m. EDT / 2:00 p.m. CEST at the Company’s office at La Pièce 12, 1180 Rolle/VD, Switzerland. SOPHiA GENETICS SA Date: May 8, 2025 By: /s/ Daan van Well Name: Daan van Well Title: Chief Legal and Regulatory Officer EXHIBIT INDEX Exhibit No. Description 99.1 In vi tation to the Annual General Meeting 2 025 99.2 Shareholder Annual General Meeting Notice 2025 99.3 Annual General Meeting Proxy Card (Broker) 2025 99.4 Annual General Meeting Proxy Card (Common Shareholder) 2025 EX-99.1 2 a2025agm.htm EX-99.1 Document To the shareholders of SOPHiA GENETICS SA (Nasdaq SOPH) (the Company) Invitation to the Annual General Meeting Date and Time : Wednesday, June 18, 2025, at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CEST Location : Offices of SOPHiA GENETICS SA, La Pièce 12, 1180 Rolle, Switzerland (AGM 2025) 1      Dear Shareholders, SOPHiA GENETICS was founded in 2011 by a team of biologists and data scientists. At the time, we dreamed of a world in which data and analytics would transform patient care. A world in which discoveries and insights are shared across institutions. And a world in which all patients across the globe have equal access to these insights and, in turn, to the best possible care. In 2024, AI created transformative change across industries, from self-driving cars to generative AI to virtual assistants. Despite this, healthcare has lagged in many ways. While cars have learned to drive themselves over the last few years, patient treatment has remained largely the same. Building impactful AI in healthcare comes with unique challenges. Human biology is deeply complex. The playing field is small, literally at the molecular level. And the parameters for analysis are in a constant state of fundamental change. Building AI for self-driving cars is difficult, but the rules are largely set. The roads are paved and marked. The turns are perceivable. The physical space is understood and well-defined. While challenges to building effective AI in healthcare exist, the mission is not impossible. It requires three ingredients: a deep understanding of biology, advanced algorithms, and large datasets, whic